Etoposide, Filgrastim, and Plerixafor in Improving Stem Cell Mobilization in Treating Patients With Non-Hodgkin Lymphoma

ClinicalTrials.gov ID: NCT01408043

Public ClinicalTrials.gov record NCT01408043. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 21, 2026, 12:54 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Study of Hematopoietic Stem Cell Supermobilization in Patients With Non-Hodgkin Lymphoma

Study identification

NCT ID: NCT01408043
Recruitment status: Terminated
Study type: Interventional
Phase: Not applicable
Lead sponsor: Case Comprehensive Cancer Center; Other
Enrollment: 25 participants

Conditions and interventions

Conditions

Interventions

etoposide Drug
filgrastim Biological
leukapheresis Procedure
plerixafor Drug

Drug · Biological · Procedure

Eligibility (public fields only)

Age range: 18 Years to 78 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Sep 30, 2011
Primary completion: Apr 30, 2016
Completion: Apr 30, 2016
Last update posted: Jun 13, 2019

2011 – 2016

United States locations

U.S. sites: 1
U.S. states: 1
U.S. cities: 1

Facility	City	State	ZIP	Site status
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center	Cleveland	Ohio	44195	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT01408043, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jun 13, 2019 · Synced May 21, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01408043 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →